Can myelofibrosis be prevented?

Some cases develop after another bone marrow disorder, including essential thrombocythaemia or polycythaemia vera. Regular follow-up for those conditions cannot promise prevention, but it can identify changes that need assessment.

Myelofibrosis is a blood cancer in which abnormal blood-forming cells disrupt the bone marrow and lead to scarring. It may arise on its own or follow another myeloproliferative condition. Everyday choices have not been shown to stop these marrow changes from developing.

This distinction matters: healthy habits can support general wellbeing and treatment tolerance, but they are not a substitute for blood monitoring or specialist care. Having a related condition does not mean that progression is certain.

Keep scheduled haematology visits and blood tests if you have essential thrombocythaemia, polycythaemia vera or another monitored blood disorder. Report meaningful changes between appointments, take prescribed treatment as directed and share a complete list of medicines and supplements.

Avoid tobacco, eat in a way that supports your nutritional needs, remain active within your abilities and discuss workplace or environmental exposures with a clinician. These measures support overall health; they should not be presented as a proven method of preventing myelofibrosis.

Arrange a clinical review for persistent unexplained tiredness, breathlessness, easy bruising or bleeding, repeated infections, drenching night sweats, unplanned weight loss, abdominal fullness or pain beneath the left ribs. Seek urgent help for heavy bleeding, severe breathlessness, fainting or chest pain, regardless of the suspected cause.

You might ask why blood monitoring is recommended, which result changes would prompt further testing, what symptoms should be reported between visits, and whether your personal or family medical history changes the follow-up plan.